Using techniques such as DNase-seq, ChIP-seq, and algorithms such as Wellington, we can begin to document the TF-binding events that confer cell identity, developmental processes or which underpin aberrant regulation in diseases such as cancer. This evidence concerns the gene TF and cancer.